Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Income from Continuing Operations (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 16 years of Income from Continuing Operations data on record, last reported at 1147000.0 in Q2 2025.

  • For Q2 2025, Income from Continuing Operations rose 83.81% year-over-year to 1147000.0; the TTM value through May 2025 reached 38717000.0, down 514.93%, while the annual FY2025 figure was 38717000.0, 514.93% down from the prior year.
  • Income from Continuing Operations reached 1147000.0 in Q2 2025 per LFCR's latest filing, up from 14769000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 16466000.0 in Q2 2021 and bottomed at 36998000.0 in Q2 2023.
  • Average Income from Continuing Operations over 5 years is 5376444.44, with a median of 6896500.0 recorded in 2022.
  • Peak YoY movement for Income from Continuing Operations: skyrocketed 3767.26% in 2021, then plummeted 823.35% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 1272000.0 in 2021, then tumbled by 823.35% to 9201000.0 in 2022, then soared by 254.79% to 14242000.0 in 2023, then plummeted by 146.14% to 6571000.0 in 2024, then soared by 82.54% to 1147000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 1147000.0 in Q2 2025, 14769000.0 in Q1 2025, and 6571000.0 in Q4 2024.